Neuromuscular Study Group 2024 (NMSG)

Back

The FORCE™ platform resolves Pompe pathology in mice by delivering acid alpha glucosidase to muscle and central nervous system (poster)

View

The FORCE™ platform demonstrates prolonged DUX4 suppression leading to resolution of muscle pathology in an FSHD mouse model (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.